News
On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic ...
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...
Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...
1d
The Palladium-Item on MSNHere's what to know about the FDA's COVID-19 vaccine changesThe FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
1d
Clinical Trials Arena on MSNNavigating the FDA’s accelerated approval pathways for oncology drugsAt CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results